FindTrial
Sign In

Effect of COVID 19 on lymphocyte and eosinophil count

CORRELATION OF ABSOLUTE EOSINOPHIL AND LYMPHOCYTE COUNTS IN SEVERITY OF COVID -19 PATIENTS: A PROSPECTIVE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028422
Enrollment
150
Registered
2020-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

AIIMS Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult (age group >18) COVID positive patients getting admitted in our hospital would be recruited for the study.

Exclusion criteria

Exclusion criteria: Pregnant patients, blood malignancies, hereditary eosinophilic syndrome, or any other condition that can affect eosinophil/ lymphocyte count

Design outcomes

Primary

MeasureTime frame
To evaluate the relationship between blood cells parameters (EOS, lymphocyte, Lymphocyte/neutrophil ratio) and disease severity.Timepoint: 4 month—

Secondary

MeasureTime frame
2. To evaluate the correlation between blood cells parameters (circulating EOS, lymphocyte counts) and patientsâ?? outcome: death, improvement or deterioration in the condition of the patient to be reclassified into other group.Timepoint: 4 month—

Countries

India

Contacts

Public ContactDR AMARJEET KUMAR

AIIMS PATNA

amarjeetdmch@gmail.com9570890646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026